BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Prokunina-Olsson L. Genetics of the Human Interferon Lambda Region. J Interferon Cytokine Res 2019;39:599-608. [PMID: 31070498 DOI: 10.1089/jir.2019.0043] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Onabajo OO, Wang F, Lee MH, Florez-Vargas O, Obajemu A, Tanikawa C, Vargas JM, Liao SF, Song C, Huang YH, Shen CY, Banday AR, O'Brien TR, Hu Z, Matsuda K, Prokunina-Olsson L. Intracellular Accumulation of IFN-λ4 Induces ER Stress and Results in Anti-Cirrhotic but Pro-HCV Effects. Front Immunol 2021;12:692263. [PMID: 34497603 DOI: 10.3389/fimmu.2021.692263] [Reference Citation Analysis]
2 Roy S, Guha Roy D, Bhushan A, Bharatiya S, Chinnaswamy S. Functional genetic variants of the IFN-λ3 (IL28B) gene and transcription factor interactions on its promoter. Cytokine 2021;142:155491. [PMID: 33725487 DOI: 10.1016/j.cyto.2021.155491] [Reference Citation Analysis]
3 Gadalla SM, Wang Y, Wang T, Onabajo OO, Banday AR, Obajemu A, Karaesman E, Sucheston-Campbell L, Hahn T, Sees JA, Spellman SR, Lee SJ, Katki HA, Prokunina-Olsson L. Association of donor IFNL4 genotype and non-relapse mortality after unrelated donor myeloablative haematopoietic stem-cell transplantation for acute leukaemia: a retrospective cohort study. Lancet Haematol 2020;7:e715-23. [PMID: 32976751 DOI: 10.1016/S2352-3026(20)30294-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
4 Rugwizangoga B, Andersson ME, Kabayiza JC, Nilsson MS, Ármannsdóttir B, Aurelius J, Nilsson S, Hellstrand K, Lindh M, Martner A. IFNL4 Genotypes Predict Clearance of RNA Viruses in Rwandan Children With Upper Respiratory Tract Infections. Front Cell Infect Microbiol 2019;9:340. [PMID: 31637221 DOI: 10.3389/fcimb.2019.00340] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
5 De Re V, Tornesello ML, De Zorzi M, Caggiari L, Pezzuto F, Leone P, Racanelli V, Lauletta G, Zanussi S, Repetto O, Gragnani L, Rossi FM, Dolcetti R, Zignego AL, Buonaguro FM, Steffan A. PDCD1 and IFNL4 genetic variants and risk of developing hepatitis C virus-related diseases. Liver Int 2021;41:133-49. [PMID: 32937024 DOI: 10.1111/liv.14667] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 De M, Bhushan A, Chinnaswamy S. Monocytes differentiated into macrophages and dendritic cells in the presence of human IFN-λ3 or IFN-λ4 show distinct phenotypes. J Leukoc Biol 2021;110:357-74. [PMID: 33205487 DOI: 10.1002/JLB.3A0120-001RRR] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Prokunina-Olsson L, Morrison RD, Obajemu A, Mahamar A, Kim S, Attaher O, Florez-Vargas O, Sidibe Y, Onabajo OO, Hutchinson AA, Manning M, Kwan J, Brand N, Dicko A, Fried M, Albert PS, Mbulaiteye SM, Duffy PE. IFN-λ4 is associated with increased risk and earlier occurrence of several common infections in African children. Genes Immun 2021;22:44-55. [PMID: 33850301 DOI: 10.1038/s41435-021-00127-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Masselli E, Pozzi G, Carubbi C, Vitale M. The Genetic Makeup of Myeloproliferative Neoplasms: Role of Germline Variants in Defining Disease Risk, Phenotypic Diversity and Outcome. Cells 2021;10:2597. [PMID: 34685575 DOI: 10.3390/cells10102597] [Reference Citation Analysis]
9 Samayoa-Reyes G, Jackson C, Ogolla S, Sabourin K, Obajemu A, Dent AE, Prokunina-Olsson L, Rochford R. IFN-λ4 genetic variants influence clinical malaria episodes in a cohort of Kenyan children. Malar J 2021;20:196. [PMID: 33882912 DOI: 10.1186/s12936-021-03689-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Waldenström J, Hellstrand K, Westin J, Nilsson S, Christensen P, Färkkilä M, Mørch K, Langeland N, Norkrans G, Lagging M. Presence of interferon-λ 4, male gender, absent/mild steatosis and low viral load augment antibody levels to hepatitis C virus. Scand J Gastroenterol 2021;56:849-54. [PMID: 34078234 DOI: 10.1080/00365521.2021.1922750] [Reference Citation Analysis]
11 De M, Bhushan A, Grubbe WS, Roy S, Mendoza JL, Chinnaswamy S. Distinct molecular phenotypes involving several human diseases are induced by IFN-λ3 and IFN-λ4 in monocyte-derived macrophages. Genes Immun 2022;23:73-84. [PMID: 35115664 DOI: 10.1038/s41435-022-00164-w] [Reference Citation Analysis]
12 Møhlenberg M, Monrad I, Vibholm LK, Nielsen SSF, Frattari GS, Schleimann MH, Olesen R, Kjolby M, Gunst JD, Søgaard OS, O'Brien TR, Tolstrup M, Hartmann R. The Impact of IFNλ4 on the Adaptive Immune Response to SARS-CoV-2 Infection. J Interferon Cytokine Res 2021;41:407-14. [PMID: 34788130 DOI: 10.1089/jir.2021.0106] [Reference Citation Analysis]
13 Pierce SK, Schwartzberg PL, Shah NN, Taylor N. Women in immunology: 2020 and beyond. Nat Immunol 2020;21:254-8. [PMID: 32094649 DOI: 10.1038/s41590-020-0618-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Fang MZ, Jackson SS, O'Brien TR. IFNL4: Notable variants and associated phenotypes. Gene 2020;730:144289. [PMID: 31846709 DOI: 10.1016/j.gene.2019.144289] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
15 Casazza RL, Lazear HM, Miner JJ. Protective and Pathogenic Effects of Interferon Signaling During Pregnancy. Viral Immunol 2020;33:3-11. [PMID: 31545139 DOI: 10.1089/vim.2019.0076] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
16 Pang ES, Daraj G, Balka KR, De Nardo D, Macri C, Hochrein H, Masterman K, Tan PS, Shoppee A, Magill Z, Jahan N, Bafit M, Zhan Y, Kile BT, Lawlor KE, Radford KJ, Wright MD, O’keeffe M. Discordance in STING-Induced Activation and Cell Death Between Mouse and Human Dendritic Cell Populations. Front Immunol 2022;13:794776. [DOI: 10.3389/fimmu.2022.794776] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Sung PS, Shin EC. Interferon Response in Hepatitis C Virus-Infected Hepatocytes: Issues to Consider in the Era of Direct-Acting Antivirals. Int J Mol Sci 2020;21:E2583. [PMID: 32276399 DOI: 10.3390/ijms21072583] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
18 Dowling JW, Forero A. Beyond Good and Evil: Molecular Mechanisms of Type I and III IFN Functions. J Immunol 2022;208:247-56. [PMID: 35017214 DOI: 10.4049/jimmunol.2100707] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
19 Huschka H, Mihm S. Interferon-lambda (IFNL) germline variations and their significance for HCC and PDAC progression: an analysis of The Cancer Genome Atlas (TCGA) data. BMC Cancer 2020;20:1131. [PMID: 33228589 DOI: 10.1186/s12885-020-07589-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]